bioAffinity Technologies, Inc.: Japan Patent Office issues notice of allowance

What happened On Oct 8, 2026, bioAffinity Technologies, Inc. announced that the Japan Patent Office has issued a Notice of Allowance indicating its intention to grant a patent to the Company for the method of predicting the likelihood of lung cancer powered by the CyPath® Lung test for early-stage lung cancer.

Key details

• The announcement was made in an 8-K filed Oct 8, 2026 under Item 8.01 (Other events).
• The Japan Patent Office issued a Notice of Allowance for a patent covering the method of predicting the likelihood of lung cancer powered by the CyPath® Lung test for early-stage lung cancer.
• The company attached a press release dated Oct 8, 2026 as Exhibit 99.1, which the filing states is incorporated by reference.

Why it may matter This filing reports Item 8.01 (Other events), which covers the company’s announcement that the Japan Patent Office issued a Notice of Allowance for a patent application related to the CyPath® Lung test method for predicting the likelihood of lung cancer for early-stage lung cancer. The filing does not show why the insider traded or why the company acted.